Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Dec 22, 2021
Date Accepted: Apr 10, 2022

The final, peer-reviewed published version of this preprint can be found here:

Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis

Chauhan J, Aasaithambi S, Márquez-Rodas I, Formisano L, Papa S, Meyer N, Forschner A, Faust G, Lau M, Sagkriotis A

Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis

JMIR Cancer 2022;8(2):e35930

DOI: 10.2196/35930

PMID: 35699985

PMCID: 9237767

Understanding the Lived Experience of Patients with Melanoma: Real-World Evidence Generated through a European Social Media Listening Analysis

  • Jyoti Chauhan; 
  • Sathyaraj Aasaithambi; 
  • Iván Márquez-Rodas; 
  • Luigi Formisano; 
  • Sophie Papa; 
  • Nicolas Meyer; 
  • Andrea Forschner; 
  • Guy Faust; 
  • Mike Lau; 
  • Alexandros Sagkriotis

ABSTRACT

Background:

Cutaneous melanoma is an aggressive malignancy that is proposed to account for 90% of skin cancer-related mortality. Individuals with melanoma experience both physical and psychological impacts associated with their diagnosis and treatment. Health-related information is being increasingly accessed and shared by stakeholders on social media platforms.

Objective:

This study aimed to assess how individuals living with melanoma use social media to discuss their needs and provide their perceptions of the disease, from across 14 European countries.

Methods:

Social media sources including Twitter, forums, and blogs were searched using predefined search strings of keywords relating to melanoma. Manual and automated relevancy approaches filtered the extracted data for content that provided patient-centric insights. This contextualized data was then mined for insightful concepts around symptoms, diagnosis, treatment, impacts, and the lived experiences of melanoma.

Results:

A total of 182,000 posts related to melanoma were identified between November 2018‒November 2020. Following exclusion of irrelevant posts and using random sampling methodology, 864 posts were identified as relevant to the study objectives. Of the social media channels included, Twitter was the most commonly used, followed by forums and blogs. Most posts originated from the UK (38%) and Spain (16%). Sixty-two percent of relevant posts were categorized as originating from individuals with melanoma. The most frequently discussed melanoma-related topics were treatment (55%), diagnosis and tests (33%), and remission (24%). The majority of treatment discussions were about surgery (67%), followed by immunotherapy (12%). In total, 255 posts discussed the impacts of melanoma, which included emotional burden (70%), physical impacts (24%), effects on social life (17%), and financial impacts (4%).

Conclusions:

Findings from this study highlight how melanoma stakeholders discuss key concepts associated with the condition on social media, adding to the conceptual model of the patient journey. This social media listening approach is a powerful tool in exploring melanoma stakeholder perspectives, providing insights that can be used to corroborate existing data and inform future studies.


 Citation

Please cite as:

Chauhan J, Aasaithambi S, Márquez-Rodas I, Formisano L, Papa S, Meyer N, Forschner A, Faust G, Lau M, Sagkriotis A

Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis

JMIR Cancer 2022;8(2):e35930

DOI: 10.2196/35930

PMID: 35699985

PMCID: 9237767

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.